The global Patient-derived Xenograft Model Market size was valued at USD 190.6 Million in 2023, and the market is projected to reach USD 561.8 Million by the end of 2030, with growth at a CAGR of 16.7% during the forecast report 2023-2030.
As per the report, the global Patient derived Xenograft Model Market is segmented into Type, Application, and Regions. The report covers detailed information on market size, Share, Growth, Value, Volume Analysis, Demand analysis, new market entry, competition insights, market drivers, challenges, opportunities, and Restraints. Further, company profile analysis, company revenue, Strategies, Sales, company acquisition, partnership, mergers, latest trends in the industry, regional and country-level insights, and competitive intelligence data is provided in the research report.
Further, the global market is geographically divided into major regions, and countries including North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. Further, major countries focused in the global study report: United States, Canada, United Kingdom, Spain, Germany, Italy, France, Mexico, Russia, Ukraine, China, Japan, South Korea, India, Singapore, Malaysia, Australia, Qatar, Kingdom of Saudi Arabia, South Africa, Brazil, Argentina, and other countries are covered in the research study.
Patient-derived Xenograft Model market segmentation
by Indication
Lung Cancer
Pancreatic Cancer
Prostate Cancer
Breast Cancer
Other Cancer
by Model Type
• Mice
• Rats
by End-User
Geographical Classification Analysis:
- North America
- Latin America
- Europe
- Middle East and Africa
- Asia Pacific
Regional Insights:
• North American market to remain in control over the global market during 2022-2030. In the North American region, the United States occupied the highest share of the market in this region, and the US country is projected to follow the same trend over the forecast time 2022-2030, followed by Canada.
• Europe holds the second largest share producer in the global Patient derived Xenograft Model Market during the forecast period 2022-2030. Asia Pacific region is expected to be registered as the fastest-growing market in the global market by 2030.
• Most developing countries in Asia Pacific remain the focus of leading Patient-derived Xenograft Model companies, with a large portion of these companies investing in new entry and business expansion strategies
• The market in the Middle East and Africa is projected to show prominent growth opportunities in the coming years from 2023-2030. Due to the rising focus from the government of the Middle East and African countries on emerging healthcare infrastructure manufacturing and distribution are mostly contributing to the global market in the MEA region.
• The Latin American Patient-derived Xenograft Model Market registered a substantial share of the global market in 2022, and it is projected to remain a presence in the market.
|
PARAMETER |
DETAILS |
|
Market Revenue in 2023 |
USD 190.6 Million |
|
|
|
|
Market Size Growth Forecast (CAGR) |
16.7% |
|
|
|
|
Base year of Estimation |
2022 |
|
|
|
|
Historic Period |
2018-2021 |
|
|
|
|
Forecast Period |
2023-2030 |
|
|
|
|
Units |
USD Million |
|
|
|
|
Qualitative Analysis |
Porter’s Five Forces, Value Chain Analysis, Market Dynamics, Scenario Analysis, SWOT Profile, Competitive Landscape |
|
|
|
|
Geographic Scope |
- North America (US, Canada, Mexico) |
|
|
|
|
Companies Profiled |
Charles River Laboratories Inc, The Jackson Laboratory, Crown Bioscience, Inc, Altogen Labs LLC, Envigo Corporation, WuXi AppTec Inc, Oncodesign Services |
|
|
|
|
Customization Available |
Yes |
|
|
|
|
Delivery Formats |
PDF (Single User, 1-5 Users, Site License, Global License), Excel Spreadsheet, Hard Copy, PPT |
Patient-derived Xenograft Model Market Competitor Analysis
• Charles River Laboratories Inc
• The Jackson Laboratory
• Crown Bioscience, Inc
• Altogen Labs LLC
• Envigo Corporation
• WuXi AppTec Inc
• Oncodesign Services
1. Executive Summary
1.1 Introduction to Patient-derived Xenograft Model Markets
1.2 Patient-derived Xenograft Model Market Size Outlook, 2021- 2030
1.3 Growth Opportunities in Patient-derived Xenograft Model Industry
1.4 Winning Strategies for the post-pandemic future
2. Report Guide
2.1 Market Definition and Scope
2.2 Market Segmentation
2.3 Research Methodology
2.4 Forecast Methodology
2.5 List of Abbreviations
3. Growth Opportunity Analysis
3.1 Key Patient-derived Xenograft Model Market Trends
3.2 Key Patient-derived Xenograft Model Market Growth Drivers
3.3 Key Patient-derived Xenograft Model Market Growth Restraints
4 Patient-derived Xenograft Model Market Outlook – Scenario Analysis
4.1 Low Growth Case Scenario Forecasts
4.2 Reference Growth Case Scenario Forecasts
4.3 High Growth Case Scenario Forecasts
5. Patient-derived Xenograft Model Market Segmentation- Outlook by Indication
5.1 Lung Cancer Market Outlook to 2030
5.2 Pancreatic Cancer Market Outlook to 2030
5.3 Prostate Cancer Market Outlook to 2030
5.4 Breast Cancer Market Outlook to 2030
5.5 Other Cancer Market Outlook to 2030
6. Patient-derived Xenograft Model Market Segmentation- Outlook by Model Type
6.1 Mice Market Outlook to 2030
6.2 Rats Market Outlook to 2030
7. Patient-derived Xenograft Model Market Segmentation- Outlook by End-Use
7.1 Pharmaceutical And Biopharmaceutical Companies Market Outlook to 2030
7.2 Academic and Research Institutes Market Outlook to 2030
7.3 CROs & CDMOs Market Outlook to 2030
8. North America Patient-derived Xenograft Model Market Outlook and Opportunities to 2030
8.1 Market Snapshot, 2023
8.2 North America Patient-derived Xenograft Model Market Growth Opportunities
8.3 North America Patient-derived Xenograft Model Market Outlook by Application
8.4 North America Patient-derived Xenograft Model Market Outlook by Type
8.5 North America Patient-derived Xenograft Model Market Outlook by Country
8.6 United States Patient-derived Xenograft Model Market Outlook
8.7 Canada Patient-derived Xenograft Model Market Outlook
8.8 Mexico Patient-derived Xenograft Model Market Outlook
9. Europe Patient-derived Xenograft Model Market Outlook and Opportunities to 2030
9.1 Market Snapshot, 2023
9.2 Europe Patient-derived Xenograft Model Market Outlook by Application
9.3 Europe Patient-derived Xenograft Model Market Outlook by Type
9.4 Europe Patient-derived Xenograft Model Market Outlook by Country
9.5 Germany Patient-derived Xenograft Model Market Outlook
9.6 France Patient-derived Xenograft Model Market Outlook
9.7 United Kingdom Patient-derived Xenograft Model Market Outlook
9.8 Spain Patient-derived Xenograft Model Market Outlook
9.9 Italy Patient-derived Xenograft Model Market Outlook
9.10 Other Europe Patient-derived Xenograft Model Market Outlook
10. Asia Pacific Patient-derived Xenograft Model Market Outlook and Opportunities to 2030
10.1 Market Snapshot, 2023
10.2 Asia Pacific Patient-derived Xenograft Model Market Outlook by Application
10.3 Asia Pacific Patient-derived Xenograft Model Market Outlook by Type
10.4 Asia Pacific Patient-derived Xenograft Model Market Outlook by Country
10.5 China Patient-derived Xenograft Model Market Outlook
10.6 Japan Patient-derived Xenograft Model Market Outlook
10.7 India Patient-derived Xenograft Model Market Outlook
10.8 Other Asia Pacific Patient-derived Xenograft Model Market Outlook
11. Latin America Patient-derived Xenograft Model Market Outlook and Opportunities to 2030
11.1 Market Snapshot, 2023
11.2 Latin America Patient-derived Xenograft Model Market Outlook by Application
11.3 Latin America Patient-derived Xenograft Model Market Outlook by Type
11.4 Latin America Patient-derived Xenograft Model Market Outlook by Country
11.5 Brazil Patient-derived Xenograft Model Market Outlook
11.6 Argentina Patient-derived Xenograft Model Market Outlook
11.7 Other Latin America Patient-derived Xenograft Model Market Outlook
12. Middle East and Africa Patient-derived Xenograft Model Market Outlook and Opportunities to 2030
12.1 Market Snapshot, 2023
12.2 Middle East and AfricaPatient-derived Xenograft Model Market Outlook by Application
12.3 Middle East and AfricaPatient-derived Xenograft Model Market Outlook by Type
12.4 Middle East and AfricaPatient-derived Xenograft Model Market Outlook by Country
12.5 Saudi Arabia Patient-derived Xenograft Model Market Outlook
12.6 UAE Patient-derived Xenograft Model Market Outlook
12.7 South Africa Patient-derived Xenograft Model Market Outlook
12.8 Other Middle East and Africa Patient-derived Xenograft Model Market Outlook
13 Profiles of major Patient-derived Xenograft Model Companies
Charles River Laboratories Inc.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
The Jackson Laboratory
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Crown Bioscience, Inc.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Altogen Labs LLC
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Envigo Corporation
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
WuXi AppTec Inc
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Oncodesign Services
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Hera Biolabs, Inc.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
XenTech
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Abnova Corp.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
14. Appendix
14.1 Publisher’s Expertise
14.2 List of Tables and Charts
14.3 List of Exhibits
14.4 Legal Disclaimer
by Indication
Lung Cancer
Pancreatic Cancer
Prostate Cancer
Breast Cancer
Other Cancer
by Model Type
• Mice
• Rats
by End-User